ProfileGDS4718 / 230708_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 27% 20% 51% 23% 31% 45% 27% 24% 28% 29% 38% 28% 26% 24% 27% 31% 38% 24% 23% 24% 26% 32% 34% 26% 28% 32% 25% 56% 25% 22% 23% 33% 31% 28% 41% 35% 22% 34% 32% 56% 31% 23% 47% 35% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.4409727
GSM549102patient 115, normal, homogenized [OPG study]4.1659720
GSM549104patient 119, normal, homogenized [OPG study]5.542951
GSM549108patient 138, normal, homogenized [OPG study]4.2955723
GSM549119patient 077, normal, homogenized [OPG study]4.6010331
GSM549133patient 032, cancer, homogenized [OPG study]5.1576645
GSM549139patient 042, cancer, homogenized [OPG study]4.4008327
GSM549099patient 107, normal, homogenized [OPG study]4.3026924
GSM549109patient 139, normal, homogenized [OPG study]4.4746528
GSM549110patient 046, normal, homogenized [OPG study]4.4857429
GSM549114patient 063, normal, homogenized [OPG study]4.8342438
GSM549122patient 082, normal, homogenized [OPG study]4.4470428
GSM549134patient 033, cancer, homogenized [OPG study]4.3514226
GSM549136patient 036, cancer, homogenized [OPG study]4.249924
GSM549140patient 044, cancer, homogenized [OPG study]4.3896127
GSM549111patient 047, normal, homogenized [OPG study]4.5432431
GSM549113patient 057, normal, homogenized [OPG study]4.8577838
GSM549132patient 031, cancer, homogenized [OPG study]4.2907724
GSM549137patient 038, cancer, homogenized [OPG study]4.23923
GSM549142patient 047, cancer, homogenized [OPG study]4.3824124
GSM549100patient 110, normal, homogenized [OPG study]4.3961326
GSM549107patient 135, normal, homogenized [OPG study]4.6009232
GSM549115patient 068, normal, homogenized [OPG study]4.6750534
GSM549116patient 072, normal, homogenized [OPG study]4.3791326
GSM549120patient 078, normal, homogenized [OPG study]4.4425528
GSM549131patient 030, cancer, homogenized [OPG study]4.584632
GSM549118patient 074, normal, homogenized [OPG study]4.3470225
GSM549129patient 027, cancer, homogenized [OPG study]5.9038756
GSM549123patient 088, normal, homogenized [OPG study]4.3351525
GSM549124patient 006, cancer, homogenized [OPG study]4.2721522
GSM549126patient 015, cancer, homogenized [OPG study]4.2434723
GSM549128patient 025, cancer, homogenized [OPG study]4.6483233
GSM549103patient 117, normal, homogenized [OPG study]4.6240331
GSM549117patient 073, normal, homogenized [OPG study]4.4327428
GSM549138patient 041, cancer, homogenized [OPG study]5.0406141
GSM549141patient 045, cancer, homogenized [OPG study]4.6871535
GSM549130patient 028, cancer, homogenized [OPG study]4.2318122
GSM549101patient 111, normal, homogenized [OPG study]4.7450434
GSM549105patient 128, normal, homogenized [OPG study]4.6473232
GSM549106patient 134, normal, homogenized [OPG study]5.8555156
GSM549112patient 048, normal, homogenized [OPG study]4.5948631
GSM549125patient 011, cancer, homogenized [OPG study]4.2525923
GSM549127patient 024, cancer, homogenized [OPG study]5.3387647
GSM549135patient 035, cancer, homogenized [OPG study]4.7211335